CGEM vs ZBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 10, 2026

CGEM

63.9
AI Score
VS
ZBIO Wins

ZBIO

72.5
AI Score

Investment Advisor Scores

CGEM

64score
Recommendation
BUY

ZBIO

73score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CGEM ZBIO Winner
Net Income 138.00M -192.44M CGEM
Operating Income 177.26M -185.01M CGEM
ROE 23.5% -77.9% CGEM
ROA 22.4% -27.4% CGEM
Total Assets 617.24M 701.69M ZBIO
Cash 242.66M 196.58M CGEM
Current Ratio 21.47 9.93 CGEM
Free Cash Flow -101.93M -132.44M CGEM

Relative Price Performance (Last 90 Days)

CGEM 1M: -11.6% · 3M: -12.7% ZBIO 1M: -4.7% · 3M: -7.1%

Current Technical Phase

CGEM

Markdown
Sell / avoid

Price below a falling SMA50 (slope -5.6%), weak momentum, RSI 43

RSI (14): 42.6 · Price: $14.92

ZBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 51

RSI (14): 51.4 · Price: $28.23

Fundamentals Snapshot

Metric CGEM ZBIO
Market Cap — —
Forward P/E -5.9 -6.1
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% -1.0%
Gross Margin — -212.5%
Operating Margin 0.0% -77.7%
EPS -3.11 -9.63
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ZBIO is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.